Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2C6Z

crystal structure of dimethylarginine dimethylaminohydrolase I in complex with citrulline

Summary for 2C6Z
Entry DOI10.2210/pdb2c6z/pdb
Related2CI1 2CI3 2CI4 2CI5 2CI6 2CI7
DescriptorNG, NG-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1, CITRULLINE, CITRIC ACID, ... (4 entities in total)
Functional Keywordsddah i, no, nos, adma, mma, acetylation, hydrolase, metal-binding, s-nitrosylation, zinc
Biological sourceBOS TAURUS (BOVINE)
Total number of polymer chains1
Total formula weight31565.98
Authors
Frey, D.,Braun, O.,Briand, C.,Vasak, M.,Grutter, M.G. (deposition date: 2005-11-16, release date: 2006-05-17, Last modification date: 2023-12-13)
Primary citationFrey, D.,Braun, O.,Briand, C.,Vasak, M.,Grutter, M.G.
Structure of the Mammalian Nos Regulator Dimethylarginine Dimethylaminohydrolase: A Basis for the Design of Specific Inbitors
Structure, 14:901-, 2006
Cited by
PubMed Abstract: Dimethylarginine dimethylaminohydrolase (DDAH) is involved in the regulation of nitric oxide synthase (NOS) by metabolizing the free endogenous arginine derivatives N(omega)-methyl-L-arginine (MMA) and N(omega),N(omega)-dimethyl-L-arginine (ADMA), which are competitive inhibitors of NOS. Here, we present high-resolution crystal structures of DDAH isoform 1 (DDAH-1) isolated from bovine brain in complex with different inhibitors, including S-nitroso-L-homocysteine and Zn2+, a regulator of this mammalian enzyme. The structure of DDAH-1 consists of a propeller-like fold similar to other arginine-modifying enzymes and a flexible loop, which adopts different conformations and acts as a lid at the entrance of the active site. The orientation and interaction mode of inhibitors in the active site give insight into the regulation and the molecular mechanism of the enzyme. The presented structures provide a basis for the structure-based development of specific DDAH-1 inhibitors that might be useful in the therapeutic treatment of NOS dysfunction-related diseases.
PubMed: 16698551
DOI: 10.1016/J.STR.2006.03.006
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.2 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon